Insider · CIK 0001790518
Hui Liu
Files at MRUS (Merus N.V.), RLYB (Rallybio Corp). First filing -, latest -.
In brief
Hui Liu files SEC Form 4 as director and officer at MRUS (Merus N.V.), and also at RLYB (Rallybio Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hui Liu has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | RLYB Rallybio Corp | MOption exercise Common Stock | +3,562 | $2.38 | $8,478 | 3,562 | 15 d ago |
| Sep 24, 2026 | RLYB Rallybio Corp | MOption exercise Common Stock | +8,482 | $7.60 | $64k | 12,044 | 15 d ago |
| Sep 24, 2026 | RLYB Rallybio Corp | MOption exercise Option (Right to Buy)derivative | -3,562 | $0.00 | $0 | 0 | 15 d ago |
| Sep 24, 2026 | RLYB Rallybio Corp | MOption exercise Option (Right to Buy)derivative | -8,482 | $5.60 | $47k | 0 | 15 d ago |
| May 13, 2025 | RLYB Rallybio Corp | AGrant or award Option (Right to Buy)derivative | +28,500 | $0.00 | $0 | 28,500 | May 15, 2025 |
| Oct 10, 2023 | MRUS Merus N.V. | AGrant or award Restricted Stock Unitsderivative | +5,000 | - | - | 5,000 | Oct 11, 2023 |
Questions about Hui Liu
Answered from the filings on this page, as of the latest one.
Is Hui Liu buying or selling?
Hui Liu has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hui Liu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hui Liu has 0.
Where does Hui Liu file Form 4?
Hui Liu has filed Form 4 at MRUS (Merus N.V.) as EVP, CBO & Head of Merus US; RLYB (Rallybio Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.